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ABSTRACT 
 
Carvedilol is widely prescribed for long-term hypertension treatment. It is rapidly absorbable by 
oral administration, but its bioavailability is merely about 20% in humans. Drug delivery is therefore 
imperative to overcome this weakness. One form of transdermal drug delivery system is a patch. 
Transdermal patch is composed of various systems, for instance, a reservoir that uses a rate control 
layer to manage the rate of drug release. This research aimed to observe the effect of using resin gum 
as the control of drug release rate on the physical characteristics and release of carvedilol in a 
transdermal patch. The patches were prepared in 5 formulas with different quantities of resin gum, 
namely 50, 100, 150, 200, and 250 mg. Afterward, they were evaluated physically, and their 
dissolution and diffusion rates were analyzed. The results showed that resin gum with concentrations 
of 150 mg and 200 mg was physically qualified for rate control. Besides, the results of dissolution and 
diffusion tests revealed that transdermal patches with 150 mg of resin gum exhibited the best drug 
release and penetration.  
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INTRODUCTION 
Carvedilol is a non-selective β-blocker that can block α-1, β-1, and β-2 adrenergic receptors. It 
is widely prescribed for long-term hypertension treatment. Clinically, it has been proven not only to 
treat hypertension but also to be used in myocardial infarction and congestive heart failure. It is rapidly 
absorbable when administered orally. However, its bioavailability in humans is merely around 20% 
because it undergoes the first-pass metabolism that converts it into its inactive form and, thereby, 
provides no therapeutic effect. Due to the low oral bioavailability, it requires a repeated administration 
that may reduce medication compliance (Ahad et al., 2015). 
A drug delivery system is required to overcome these weaknesses. Carvedilol has a low 
molecular weight (406.5 Da) and a favorable log P (4.115) with t1/2= 6 hours, allowing it to penetrate 
the lipophilic layer (Vora et al., 2013). Transdermal drug delivery system (TDDS) is a delivery system 
that maintains the effectiveness of drug release over an extended period, reducing the intensity of 
administration and side effects associated with oral administration routes (Patel et al., 2012). One form 
of TDDS is a patch. Transdermal patches are pharmaceutical preparations with a variety of size 
containing one or more active ingredients intended to be applied to the skin and accommodate these 
ingredients to enter the systemic circulation after passing through the skin barrier (Premjee et al., 
2011). TDDS has several advantages, including convenience in drug delivery, pain reduction, and easy 
treatment in case of systemic toxicity (Alexander et al., 2012).  
As a dosage form, transdermal patch consists of many systems, i.e., adhesive system (using 
adhesive polymers), matrix system (using polymers as a matrix/drug container), reservoir system 
(using polymers as drug containers and controls of drug release rate,) and micro-reservoir system. This 
study prepared transdermal patches with reservoir system due to its several advantages, for instance, 
reservoirs (drug carriers) have separate adhesive layer and a control layer of drug release rate 
(Alexander et al., 2012; Saroha et al., 2011). Moreover, if the carvedilol patches were prepared with a 
matrix system, then a combination of hydrophobic and hydrophilic polymers would be needed and, at 
the same time, complicate the time of preparation. Transdermal patch with reservoir system is 
composed of active substance, matrix polymer, polymer as rate control, penetration enhancer, 
plasticizer (preventing the formation of a brittle film layer), release liner (protecting the adhesive layer 
during storage), and backing layer (the outermost layer that protects the patch) (Premjeet et al., 2011).  
Polymers as rate control have an essential role in a transdermal patch with reservoir systems. An 
example of these polymers is resin gum. It is mainly used as an emulsifier and a stabilizer in the 
production of colors, paints, inks, and aromatic emulsions in food and cosmetic industry, primarily 
because it is one of the relatively cheap and readily available polymers (Coppen, 1995). Resin gum is a 
hydrophobic polymer that can form a good film layer and release the drug gradually, which justifies its 
application as excellent rate control. Previous studies prove that it can create a functional film layer 
with the addition of 40% of dibutyl phthalate (hydrophobic) as a plasticizer. The drug diffusion 
through this film provides zero-order release over an extended period at a controlled level (Mundada 
and Avari, 2009). This reason has encouraged researchers to observe the effect of using resin gum as 
rate control on the physical characteristics and the release of carvedilol in a transdermal patch.  
 
MATERIALS AND METHODS 
 
Materials 
The materials used in this research were carvedilol (Sigma) and resin gum (Biuma Bhakti).  
 
Formulation of transdermal patches (Mundada and Avari, 2009; Rajhpur and Lakshmi, 2015)  
The five formulas used to prepare the carvedilol transdermal patches are presented in Table I. 
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Table I. Formulas of carvedilol transdermal patch  
 
Formulas Carvedilol 
(mg) 
3% HPMC 
K100M Gel 
(mg) 
Resin Gum 
(mg) 
Dibutyl phthalate 
(%, from the amount of 
resin gum) 
F1 13 100 50 40 
F2 13 100 100 40 
F3 13 100 150 40 
F4 13 100 200 40 
F5 13 100 250 40 
 
Preparation of carvedilol-containing gel 
HPMC K100M was dispersed in distilled water. The dispersion solution was stirred until 
homogeneous using a magnetic stirrer and then left to rest for ± 24 hours at room temperature until it 
expanded and gelatinized. The carvedilol was dissolved in methanol, added to the gel, and stirred until 
homogeneous. Afterward, the gel in which carvedilol was present was observed organoleptically and 
evaluated for content uniformity. 
 
Preparation of rate control layer 
The resin gum was dissolved in chloroform until it reached a concentration of 10% w/v. It was 
then added with 40% dibutyl phthalate, stirred until homogeneous, and placed in a Petri dish. After a 
film layer was formed, it was evaluated organoleptically and tested experimentally for thickness, 
weight uniformity, folding endurance, and water vapor transmission rate.  
 
Preparation of transdermal patches 
The gel containing carvedilol was placed on the backing layer, and the resin gum layer was put 
on top of it. Afterward, the transdermal patch was closed with a release liner and tested for in vitro 
drug release and diffusion. 
 
Evaluations 
Organoleptic analysis of carvedilol-containing gel (Sonjoy et al., 2011; Rajhpur and Lakshmi, 
2015) 
This evaluation included visual observation on the shape, color, and odor of the gel. 
 
Content uniformity analysis of carvedilol-containing gel (Sonjoy et al., 2011; Rajhpur and 
Lakshmi, 2015)  
This test was performed by pouring the gel into a volumetric flask. The gel was added with 10 
mL of methanol and stirred in a shaker bath for 24 hours. Then, it was added with phosphate buffer 
solution (pH 7.4) up to 100 mL. The absorbent was measured with UV-Vis spectrophotometer at a 
wavelength of 286 nm.  
 
Organoleptic analysis of rate control layer (Sonjoy et al., 2011) 
This evaluation included visual observation on the shape, color, and odor of the rate control layer. 
 
Thickness measurement of rate control layer (Sonjoy et al., 2011) 
The thickness of rate control layer was measured using a caliper. The result represented the 
average thickness of the rate control layers of three different patches.  
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Weight uniformity analysis of rate control layer (Sonjoy et al., 2011) 
Three rate control layers of each formula were weighed one by one with an analytical scale. The 
variation of their weight was calculated.  
 
Folding endurance test of rate control layer (Sonjoy et al., 2011) 
This test was performed by folding the rate control layer repeatedly for 300 times until it was 
broken or folded. The number of folds that could be applied to the layer without breaking it was 
selected as the degree of folding endurance.  
 
Water vapor transmission rate (WVTR) analysis of rate control layer (Sonjoy et al., 2011) 
This test used glass vials as a transmission cell. The vials were washed and then dried in the 
oven. Afterward, 1 gram of calcium chloride was placed in them, and the rate control was set on the 
edge with the help of an adhesive. The accurate weight of the vials was recorded. They were put in a 
desiccator containing a saturated potassium chloride solution with a relative humidity of 63%. The 
vials were removed after 72 hours. The water vapor transmission rate was calculated using Eq. 1. 
 
 ………………………………………………………...…………..... (Eq. 1). 
 
where: 
W = Weight difference or reduction (gram) 
L = Thickness of transdermal patch (cm) 
S = Area (cm
2
) 
 
In vitro drug release test of transdermal patch (Sonjoy et al., 2011) 
The drug release was measured using a U.S.P dissolution tester at a temperature of 37°C±1°C 
and stirred at 50 rpm. The transdermal patches were placed on the glass object with the help of 
cyanoacrylate adhesive substance so that the drug could not separate from the glass object. The glass 
object was inserted into a chamber containing 900 mL of phosphate buffer solution (pH 7.4). 
Afterward, 5 ml of the solution in the chamber was discharged every hour up to the twentieth hour and 
diluted with phosphate buffer solution (pH 7.4). The absorbent was read using a UV-Vis 
spectrophotometer at a wavelength of 286 nm. 
 
In vitro drug penetration test of transdermal patch (Sonjoy et al., 2011)  
This test used the Frans diffusion cell tool. The transdermal patches were placed on the 
Millipore membrane (pore size= 0.22 μm) in the Franz diffusion cell tool. Millipore membranes were 
inserted between the donor and receptor compartments. The receptor compartment contained 100 mL 
of phosphate buffer solution (pH 7.4). This buffer was stirred with a magnetic stirrer at 100 rpm and a 
temperature of 37°C±1°C. It was drawn by 5 mL per predefined time interval for 24 hours. The 
solution was diluted with phosphate buffer solution (pH 7.4) and then analyzed using a UV-Vis 
spectrophotometer at a wavelength of 286 nm. 
 
Statistical analysis 
The physical characteristics of the rate control layer and the transdermal patch, as identified 
from the evaluations, were analyzed using One-way ANOVA with tα = 0.05. 
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RESULTS AND DISCUSSION 
The organoleptic properties and content uniformity of the carvedilol-containing gel 
The gel base used in this research was a high viscosity grade of hydroxypropyl 
methylcellulose (HPMC) with a concentration of 3%. The organoleptic test results of the HPMC gel 
are presented in Table II.  
 
Table II. The organoleptic properties of HPMC gel  
 
Organoleptic Characteristics Results 
Shape Gel 
Color Transparent (colorless) 
Odor Odorless 
 
The carvedilol content in each part of the gel has to be uniform. Therefore, the content 
uniformity of HPMC gel in which carvedilol is present is necessary to evaluate. The carvedilol-
containing HPMC gel was sampled by 100 mg, dissolved in phosphate buffer solution (pH 7.4), and 
measured using a UV-Vis spectrophotometer at a wavelength of 286 nm. As presented in Table III, the 
results indicate that the carvedilol content in the tested HPMC gel meets the standard of content 
uniformity, i.e., no deviation above 15% (Kemenkes RI, 2014). 
 
Table III. The results of content uniformity test of carvedilol-containing HPMC gel 
 
No Results (%) 
1. 100.5 
2. 99.8 
3. 99.5 
4. 100.3 
5. 100.2 
6. 99.7 
7. 99.8 
8. 100.2 
9. 100.4 
10. 99.6 
Mean 100.0 
 
The evaluation results of the rate control layer  
The rate control layer was prepared with resin gum using the film casting solvent method, which 
evaporated the solvent used in the preparation of the rate control layer. The film layer formed in this 
process was evaluated organoleptically. As summarized in Table IV, the results showed that formulas 
3 and 4 had the most favorable organoleptic properties because they produced non-friable and non-
sticky rate control layers. These characteristics are influenced by the amount of resin gum used in each 
formula. The higher the amount of the resin gum used to a certain extent, the better the film layer 
(Mundada and Avari, 2009). 
The next evaluation was the thickness measurement of the film layer using a micrometer scrub. 
The number of polymers used in the preparation of the rate control layer affects the thickness of the 
film layer (Mundada and Avari, 2009; Babu et al., 2012). The results, as presented in Table V, 
affirmed that the amount of resin gum used in the preparation could produce film layers with 
significantly different thickness (p <0.05). 
Aside from thickness, the research analysis included the weight uniformity evaluation of the rate 
control layer. Three transdermal patches of each formula were weighed using an analytical scale. The 
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amount of resin gum used as the former of film layer affects the weight of the dosage form (Mundada 
and Avari, 2009). As listed in Table VI, the results proved that the amount of resin gum used in the 
preparation could produce rate control layer with significantly different weights (p<0.05). 
 
Table IV. The results of the organoleptic test of the resin gum-based rate control layer 
  
Formulas Results 
Formula 1 Shape: Friable thin film layer 
Color: Transparent brown 
Odor: Odorless 
Formula 2 Shape: Slightly friable, thin film layer 
Color: Transparent brown 
Odor: Odorless 
Formula 3 Shape: Thin film layer 
Color: Transparent brown 
Odor: Odorless 
Formula 4 Shape: Thin film layer 
Color: Transparent brown 
Odor: Odorless 
Formula 5 Shape: Slightly sticky, thin film layer 
Color: Transparent brown 
Odor: Odorless 
 
Table V. The thickness of the resin gum-based rate control layer 
 
Formulas Results (µm) 
Formula 1 83.5 ± 0.45 
Formula 2 95.6 ± 1.01 
Formula 3 130.2 ± 0.58 
Formula 4 167.8 ± 0.34 
Formula 5 201.7 ± 0.48 
 
Table VI. The weight uniformity of the resin gum-based rate control layer 
 
Formulas Results (mg) 
Formula 1 53.86 ± 0.28 
Formula 2 102.55 ± 0.30 
Formula 3 153.75 ± 0.31 
Formula 4 203.30 ± 0.55 
Formula 5 252.48 ± 0.32 
 
The folding endurance test was performed by folding the patches 300 times in the same section. 
A good film can withstand at least 300 folds (Barhate et al., 2011). The evaluation results showed that 
the film layer of formula 1 was only able to survive 238 folds, while the one created using formula 2 
survived 273 folds. Similar case applied to formula 5 where the film layer endured 280 folds. 
However, the film layers of formulas 3 and 4 were able to withstand the three-hundredth fold without 
any damage. Such endurance to folding was caused by the use of 40% of dibutyl phthalate as a 
plasticizer (Mundada and Avari, 2009). The amount of the resin gum used in the formula potentially 
affects the endurance of the film layer to folding. The higher the amount of the polymers used as the 
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former of the film layer, the stronger its endurance to folding (Barhate et al., 2011). The number of 
folding endured by the film layers continually increased from formula 1 to formulas 3 and 4 that used 
150 mg and 200 mg of resin gum. However, this number decreased when the formula used 250 mg of 
resin gum because it resulted in a slightly sticky layer. These evaluation results suggested that 
formulas 3 and 4 produced the best film layers of resin gum. Furthermore, they affirm that the amount 
of resin gum in a formula can create significantly different endurance to folding (p <0.05). 
The water vapor transmission rate (WVTR) test was performed by measuring the amount of 
water vapor that passed through the film layer. This amount is influenced by the thickness of said film 
layer (Premjeet et al., 2011). As summarized in Table VII, the test results showed that a thicker film 
layer allowed a smaller amount of water to pass through. They also proved that the amount of resin 
gum used in the preparation of the rate control layer produced different thickness and, therefore, 
significantly different water vapor transmission rate (p <0.05). 
 
Table VII. The water vapor transmission rate of the resin gum-based rate control layer  
 
Formulas Results (g.cm/cm
2
) (72 hours) 
Formula 1 7.73 ± 0.07 
Formula 2 7.11 ± 0.12 
Formula 3 6.38 ± 0.08 
Formula 4 5.85 ± 0.04 
Formula 5 5.02 ± 0.10 
 
The evaluation results of the carvedilol transdermal patch  
The dissolution test was performed to identify the ability of the transdermal patch to release 
active substance from its dosage form. It tested the carvedilol transdermal patches prepared with 
formulas 3 and 4 because they were the best and most eligible according to the physical evaluation 
results of the resin gum-based film layer. The results of the dissolution test of the carvedilol 
transdermal patch are summarized in Table VIII. The drug release in a transdermal dosage form with 
reservoir system is influenced by the properties of the polymer, such as rate control, the thickness of 
the rate control layer, and the characteristics of the active ingredient (Premjeet et al., 2011). Based on 
the dissolution test results, formula 3 released more active substance compared to formula 4 despite 
the less significant thickness difference between their rate control layers. This finding affirms that a 
thicker rate control layer decreases the speed of the active substance to penetrate; in other words, the 
active ingredient takes a longer time to exit the dosage form (Sonjoy et al., 2011). The statistical 
analysis results indicated that the two formulas yielded inconsiderably different percentage of 
dissolved active ingredient (p> 0.05).  
In addition to the dissolution test, the evaluation of carvedilol patch also included diffusion test. 
It was performed using Franz diffusion cell. The Millipore membrane used to simulate skin layer in 
this test had to be impregnated first with isopropyl myristate to produce oily membrane and mimic the 
structure of stratum corneum. The drug diffusion test started with identifying the optimum 
impregnation time in 10, 30, 45, 60, and 75 minutes. As presented in Table IX, the percentages 
showed that the optimum impregnation time was 10 minutes (Hendradi and Martodihardjo, 1997).  
The diffusion test was performed to identify the ability of active substances to penetrate the 
stratum corneum on the skin to be able to enter the systemic circulation. It tested the carvedilol 
transdermal patches prepared with formulas 3 and 4 due to their most favorable organoleptic properties 
and degrees of folding endurance. It used a diffusion tool that was connected to a peristaltic pump. The 
receptor compartment containing 330 mL of phosphate buffer solution (pH 7.4) was conditioned at a 
temperature 37
o
C±1
o
C by running water with the same temperature into the water jacket. The previous 
study used Eudagrit L to form the rate control layer and Span 80 as a penetration enhancer, and it 
resulted in 90% dissolved active substance in 24 hours (Tanwar et al., 2007).  
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Table VIII. The dissolution test results of the carvedilol transdermal patch  
 
Time (hour) Results (%) Results (%) 
F3 F4 
0 0 ± 0 0 ± 0 
1 8.98 ± 0.13 5.25 ± 0.19 
2 15.67 ± 0.05 7.15 ± 0.07 
3 22.37 ± 0.14 15.67 ± 0.14 
4 33.90 ± 0.23 23.54 ± 0.12 
5 40.86 ± 0.21 30.78 ± 0.24 
6 52.35 ± 0.18 40.44 ± 0.13 
8 60.75 ± 0.13 48.92 ± 0.21 
10 68.34 ± 0.16 52.45 ± 0.07 
14 73.54 ± 0.18 60.34 ± 0.03 
24 80.21 ± 0.16 68.62 ± 0.13 
 
Table IX. The optimization of millipore membrane 
 
Time 
(minute) 
% average impregnation 
(%) 
10 9.08 ± 0.3872 
30 14.89 ± 0.4979 
45 22.10 ± 0.7349 
60 28.68 ± 0.2573 
75 31.13 ± 0.7556 
 
 
Figure 1. The diffusion test results of carvedilol transdermal patches prepared with 
formula 3 and formula 4 
 
The percentage of the diffused active substance by the carvedilol transdermal patch prepared 
with formula 3 was higher than formula 4, as illustrated in Figure I. This difference was caused by the 
thicker rate control layer in formula 4 (72.7%) compared to formula 3 (60.01%), which prevented drug 
from penetrating to the rate control layer and reduced the amount of the diffused drug. A long drug 
release is also influenced by the hydrophobicity of the rate control layer. Resin gum is a hydrophobic 
polymer; therefore, medicinal materials can hardly penetrate it and diffuse out of a dosage system. In 
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this case, only a smaller amount of drug can penetrate the skin and enter the systemic circulation 
(Babu et al., 2012). Compared to the previous study (Tanwar et al., 2007), the diffusion test results 
showed that transdermal patches with resin gum as the rate control layer exhibited a reasonably good 
diffusion even without the addition of penetration enhancer. The statistical analysis results showed that 
carvedilol patches prepared with formulas 3 and 4 produced insignificantly different percentage of 
diffused active substance (p> 0.05). 
 
CONCLUSIONS 
The results indicate that a higher concentration of resin gum as a rate control affects the physical 
properties of the formed rate control layer. The amount of resin gum used in the preparation also 
determines the results of the dissolution and diffusion test of the carvedilol transdermal patch. Formula 
3, with 150 mg of resin gum, is the best formula.  
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